-
-
-
-
-
-
-
Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
ACETO Corp (ACET) Tops Q3 EPS by 1c
-
-
-
-
-
-
-
Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
ACETO Corp (ACET) Tops Q4 EPS by 3c
-
-
-
-
-
-
-
Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones
-
-
-
-
-
-
-
Adicet Bio (ACET) Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
-
-
-
-
-
-
-
Adicet Bio Announces FDA Clearance of IND Amendment to Evaluate ADI-001 in Idiopathic Inflammatory Myopathy and Stiff Person Syndrome
-
1,230,620 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


